Syndax names Steve Sabus as Chief Commercial Officer
The Fly

Syndax names Steve Sabus as Chief Commercial Officer

Syndax Pharmaceuticals announced the appointment of Steve Sabus to the role of Chief Commercial Officer, effective December 5. Sabus brings to Syndax more than 30 years of commercial experience launching drugs and building sales and marketing organizations within the biopharmaceutical industry. As Chief Commercial Officer, Sabus will oversee all commercial functions, including the development of critical launch initiatives, sales planning and commercial strategy. Prior to joining Syndax, Sabus served as Chief Commercial Officer at Turning Point Therapeutics, before being acquired by BMS.

Published first on TheFly

See Insiders’ Hot Stocks on TipRanks >>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App